Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Critical Reviews in Oncology/Hematology|November 18, 2019
The opportunistic effect of exosomes on Non-Hodgkin Lymphoma microenvironment modulationMara Fernandes, Ana Luísa Teixeira, Rui Medeiros
Cancers|October 17, 2018
Involving the microRNA Targetome in Esophageal-Cancer Development and BehaviorFrancisca Dias, Mariana Morais, Ana Luísa Teixeira, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 8, 2024
Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insightsÂngela Alves, Rui Medeiros, Ana Luísa Teixeira, et al.
International Journal of Molecular Sciences|January 11, 2022
ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL CohortMara Fernandes, Herlander Marques, Ana Luísa Teixeira, et al.
Biomedicines|June 24, 2022
Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot StudyMara Fernandes, Herlander Marques, Ana Luísa Teixeira, et al.
Pharmacogenomics|January 16, 2018
miRNAs as potential regulators of mTOR pathway in renal cell carcinomaInês Nogueira, Francisca Dias, Ana Luísa Teixeira, et al.
Biomedicines|December 24, 2021
Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical PerspectivesMara Fernandes, Herlander Marques, Ana Luísa Teixeira, et al.
Cytogenetic and Genome Research|July 14, 2020
Loss of Chromosome Y and Its Potential Applications as Biomarker in Health and Forensic SciencesBela Barros, Mariana Morais, Ana Luísa Teixeira, et al.
Pharmaceutics|November 27, 2024
MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration-Where Are We Now?Mariana Ferreira, Mariana Morais, Rui Medeiros, et al.
Cancers|December 24, 2021
miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin's Lymphoma: Moving towards an RNA-Guided Precision MedicineMara Fernandes, Herlander Marques, Ana Luísa Teixeira, et al.
Pageof 5